1. Home
  2. UG vs CVM Comparison

UG vs CVM Comparison

Compare UG & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$7.08

Market Cap

36.5M

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.67

Market Cap

30.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
CVM
Founded
1942
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
30.1M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
UG
CVM
Price
$7.08
$1.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.9K
★ 108.8K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
★ 7.10%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.20
N/A
Revenue
★ $10,545,468.00
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.25
★ N/A
Revenue Growth
N/A
★ 65.45
52 Week Low
$5.58
$0.89
52 Week High
$8.45
$10.83

Technical Indicators

Market Signals
Indicator
UG
CVM
Relative Strength Index (RSI) 50.51 60.05
Support Level $6.90 $0.95
Resistance Level $7.48 $1.76
Average True Range (ATR) 0.19 0.09
MACD 0.01 0.01
Stochastic Oscillator 35.35 75.41

Price Performance

Historical Comparison
UG
CVM

About UG United-Guardian Inc.

United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: